Generation Comparison and Pharmacokinetics
The primary classification divides antihistamines into first and second generations, distinguished mainly by their sedative properties.
- First-generation drugs: Exhibit pronounced sedative effects and low selectivity. In addition to H1-receptors, they block muscarinic acetylcholine receptors and $\alpha$-adrenergic receptors, leading to adverse effects. They readily cross the central nervous system due to high lipophilicity, and their duration of action is 4–6 hours.
- Second-generation drugs: Characterized by high selectivity for H1-receptors and minimal penetration across the blood-brain barrier (BBB) due to low lipophilicity and active efflux by the P-glycoprotein transporter pump. They are non-sedating, and their duration of action reaches 12–24 hours.
Second-generation drugs are metabolized in the liver via the CYP3A4 isoenzyme. Some are prodrugs converted in the body into active metabolites, such as loratadine converting to desloratadine.
Clinical Indications and Special Considerations
The primary indication for H1-receptor blockers is allergic disease. They are effective for the prevention and treatment of urticaria, pruritus, allergic rhinitis, conjunctivitis, and angioedema (Quincke's edema). However, they are not the drugs of choice for anaphylactic shock or bronchial asthma.
The ability of first-generation drugs to affect the central nervous system finds specific uses:
- Used as sedatives or sleep aids, e.g., diphenhydramine.
- Used for the prevention of motion sickness (kinetosis).
- Possess antiparkinsonian activity and may be co-administered with antipsychotics to manage extrapyramidal symptoms.
Safety Profile and Adverse Reactions
Most antihistamines are well tolerated, but their pharmacological profile results in several side effects. Anticholinergic and sedative actions can function as both therapeutic properties and adverse reactions.
- Muscarinic receptor blockade effects: Dry mouth and gastrointestinal disturbances.
- CNS effects: Pronounced drowsiness and lethargy.
- Overdose: In children, may cause paradoxical excitation, seizures, and postural hypotension.
Cardiotoxicity associated with certain second-generation agents, such as astemizole and terfenadine, requires special attention. They can trigger cardiac arrhythmias, especially when metabolism is impaired. Concomitant administration with CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, macrolides, or grapefruit juice consumption) is strictly contraindicated.